{"log_id": 1749404132052229684, "direction": 0, "words_result_num": 31, "words_result": [{"probability": {"variance": 0.000539, "average": 0.990127, "min": 0.870081}, "location": {"width": 832, "top": 219, "height": 47, "left": 215}, "words": "雷奈酸锶同时服用,雷奈酸锶的吸收稍有降低(AUC降低20-25%),但是当在服用雷奈酸锶之后2"}, {"probability": {"variance": 0.000141, "average": 0.993872, "min": 0.936396}, "location": {"width": 808, "top": 263, "height": 47, "left": 215}, "words": "小时服用抗酸剂,吸收几乎未受影响。因此最好在服用雷奈酸锶2小时后再服用抗酸剂。但是"}, {"probability": {"variance": 0.003445, "average": 0.984273, "min": 0.635587}, "location": {"width": 744, "top": 308, "height": 46, "left": 214}, "words": "由于建议雷奈酸锶睡前服用而使得所推荐服药方法不能实行时,同时服用仍然可以接受"}, {"probability": {"variance": 1e-06, "average": 0.998815, "min": 0.997247}, "location": {"width": 361, "top": 356, "height": 34, "left": 252}, "words": "未观察到与口服维生素D的药物相互作用"}, {"probability": {"variance": 2.8e-05, "average": 0.996823, "min": 0.971791}, "location": {"width": 787, "top": 401, "height": 47, "left": 251}, "words": "在临床研究中服用雷奈酸锶的目标人群在同时服用其他常用药物时,未发现临床药物相互作"}, {"probability": {"variance": 0.006037, "average": 0.9818, "min": 0.480859}, "location": {"width": 827, "top": 445, "height": 49, "left": 209}, "words": "用的证据或血锶水平相应升高的证据。包括:非爵体类抗炎药物(包括乙酰水杨酸),苯胺类(如扑"}, {"probability": {"variance": 0.000949, "average": 0.99066, "min": 0.831441}, "location": {"width": 828, "top": 491, "height": 49, "left": 209}, "words": "热息痛),H2阻滞剂和质子泵抑制剂,利尿剂,地高辛和强心甙类,治疗心脏疾病的有机硝酸和其"}, {"probability": {"variance": 0.019172, "average": 0.942713, "min": 0.375898}, "location": {"width": 827, "top": 536, "height": 50, "left": 208}, "words": "他血管扩张剂,钙通道阻滞剂,β-阴断剂,ACE抑制剂,血管紧张素ⅡI抗剂,选择性B-2肾上"}, {"probability": {"variance": 8.2e-05, "average": 0.995883, "min": 0.947235}, "location": {"width": 828, "top": 582, "height": 49, "left": 206}, "words": "腺素能受体激动剂,口服抗凝剂,血小板聚集抑制剂,他汀类药物,氯贝丁酯和苯二氮卓类衍生"}, {"probability": {"variance": 0, "average": 0.999991, "min": 0.999991}, "location": {"width": 23, "top": 630, "height": 24, "left": 207}, "words": "物"}, {"probability": {"variance": 7e-06, "average": 0.997062, "min": 0.993267}, "location": {"width": 110, "top": 719, "height": 28, "left": 211}, "words": "【药物过量】"}, {"probability": {"variance": 0.007438, "average": 0.980492, "min": 0.442572}, "location": {"width": 780, "top": 766, "height": 49, "left": 242}, "words": "健康绝经后妇女在一项临床研究中重复服用需奈酸锶4克/日长达25日,显示出良好的耐受性"}, {"probability": {"variance": 8.3e-05, "average": 0.995264, "min": 0.958556}, "location": {"width": 558, "top": 811, "height": 43, "left": 204}, "words": "健康年轻男性志愿者单次服药剂量高达11克,未导致特别的症状"}, {"probability": {"variance": 0.003761, "average": 0.979644, "min": 0.682803}, "location": {"width": 787, "top": 859, "height": 48, "left": 241}, "words": "在临床研究中发生的药物过量情况(高达4克/日,最长持续时间为147日),未观察到相关的"}, {"probability": {"variance": 3.7e-05, "average": 0.993755, "min": 0.98367}, "location": {"width": 80, "top": 905, "height": 24, "left": 201}, "words": "临床事件"}, {"probability": {"variance": 0.032726, "average": 0.869327, "min": 0.613508}, "location": {"width": 120, "top": 904, "height": 57, "left": 881}, "words": "国药公"}, {"probability": {"variance": 0.003465, "average": 0.982511, "min": 0.690259}, "location": {"width": 781, "top": 949, "height": 48, "left": 239}, "words": "牛奶和抗酸剂有助于减少活性物质的吸收。当发生严重过量时,呕可能会排出尚未吸收的"}, {"probability": {"variance": 5e-06, "average": 0.998053, "min": 0.994457}, "location": {"width": 84, "top": 994, "height": 26, "left": 198}, "words": "活性物质"}, {"probability": {"variance": 1.8e-05, "average": 0.99523, "min": 0.988523}, "location": {"width": 108, "top": 1085, "height": 27, "left": 203}, "words": "【临床试验】"}, {"probability": {"variance": 0.00011, "average": 0.991517, "min": 0.973973}, "location": {"width": 79, "top": 1132, "height": 23, "left": 200}, "words": "临床疗效"}, {"probability": {"variance": 0.004734, "average": 0.966758, "min": 0.723373}, "location": {"width": 788, "top": 1176, "height": 49, "left": 233}, "words": "骨质疏松症的定义是椎体或髋部的BMD低于正常年轻人峰值的平均值2.5SD或更多。与绝经"}, {"probability": {"variance": 7e-06, "average": 0.998288, "min": 0.985586}, "location": {"width": 827, "top": 1220, "height": 50, "left": 193}, "words": "后骨质疏松症有关的危险因素包括低骨量、低骨密度、早绝经、吸烟史和骨质疏松症家族史。骨"}, {"probability": {"variance": 0.000107, "average": 0.996405, "min": 0.945237}, "location": {"width": 531, "top": 1266, "height": 43, "left": 193}, "words": "质疏松症的临床后果是骨折。随着危险因素的数量增加而增加"}, {"probability": {"variance": 7e-06, "average": 0.997839, "min": 0.990744}, "location": {"width": 218, "top": 1312, "height": 34, "left": 229}, "words": "绝经后骨质疏松症的治疗"}, {"probability": {"variance": 0.002607, "average": 0.983127, "min": 0.719123}, "location": {"width": 779, "top": 1358, "height": 50, "left": 228}, "words": "本品的抗骨折研究项目包括2项安慰剂对照的Ⅲ期临床研究:SOTI研究和 TROPOS研究"}, {"probability": {"variance": 0.002166, "average": 0.979081, "min": 0.759945}, "location": {"width": 825, "top": 1403, "height": 50, "left": 189}, "words": "在SOTI研究中,共有1649名诊断为骨质疏松症(腰椎BMD降低和发生过椎体骨折)的绝经妇女"}, {"probability": {"variance": 0.000172, "average": 0.99356, "min": 0.922861}, "location": {"width": 828, "top": 1448, "height": 51, "left": 187}, "words": "参加,平均年龄是70岁。在 TROPOS研究中,共有5091名绝经后骨质疏松妇女降低的股骨颈"}, {"probability": {"variance": 0.009514, "average": 0.974929, "min": 0.386685}, "location": {"width": 823, "top": 1494, "height": 53, "left": 190}, "words": "BMD,半数以上发生过骨折)参加,平均年龄77岁将SOTI和 TROPOS合并在一起,在入选时"}, {"probability": {"variance": 0.000579, "average": 0.989174, "min": 0.872283}, "location": {"width": 828, "top": 1541, "height": 52, "left": 185}, "words": "年龄超过80岁的患者共有1566名(占研究人群的23.1%)。在这些治疗的基础上(2克/日雷奈酸锶"}, {"probability": {"variance": 0.004724, "average": 0.916952, "min": 0.768953}, "location": {"width": 90, "top": 1579, "height": 20, "left": 293}, "words": "0129-DL-F2"}, {"probability": {"variance": 0.001884, "average": 0.939976, "min": 0.878599}, "location": {"width": 19, "top": 1599, "height": 17, "left": 987}, "words": "/12"}], "language": 3}